Navigation Links
Will Rogers Institute to Honor World's Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.
Date:11/27/2007

Resulting in the advancement of treatment Of Cystic Fibrosis

LOS ANGELES, Nov. 27 /PRNewswire/ -- It is impossible to over estimate the effect Dr. Francis S. Collins' work has had on public health. Fifty years ago, children living with cystic fibrosis (CF) would not have been expected to live past their early teens. Thanks to the research work of Dr. Collins, and the subsequent advancement in treatment, people can now expect to live into their thirties, forties and beyond.

It is in recognition of his extraordinary work on the CF gene and identification of the human genome, that the Will Rogers Institute (WRI) will honor Dr. Collins with the inaugural "Annual Prize for Outstanding Contributions to Lung Research." The award will be presented on Thursday, December 6, 2007 at the WRI Board of Directors Meeting at the Beverly Hills Hotel.

Dr. Collins' seminal research led to the identification of the CF gene and its protein product, CFTR. Mutation of the gene results in CF, a chronic disease which attacks the lungs and other organs. It is estimated that 30,000 children and adults in the United States struggle with cystic fibrosis. More than 10 million Americans are unknowing, symptom-free carriers of the disease, which can only be identified by genetic testing.

His work has proved to be a motivator for advancements in many other genetic investigations including type 2 diabetes, neurofibromatosis and Huntington's disease.

Dr. Edward Crandall, PhD, MD, medical advisor to the Will Rogers Institute and Hastings Professor and Norris Chair of Medicine at the University of Southern California (USC), stated, "Dr. Collins was chosen by the WRI as the first recipient of the prize because his work has consistently produced outstanding and influential research that has been published in the foremost peer-review journals. He maintains a very important leadership role in his field, and is held in the highest esteem by scientists and clinicians throughout the world."

As further testament to the importance of his work, on November 5, 2007 President George W. Bush presented Dr. Collins with the Medal of Freedom, one of the nation's highest civilian honors, for his contribution to genetic research. The Human Genome Project identified the genes in human DNA, stored the data and made it available for research. This project alone has revolutionized genetic research.

A native of the east coast, Dr. Collins studied chemistry at the University of Virginia (BS) and Yale University (PhD) and received his MD from the University of North Carolina. He undertook residency training in medicine at North Carolina before returning to Yale as a Fellow in Human Genetics from 1981 to 1984. Dr. Collins was appointed Director of the National Genome Research Institute of the National Institutes of Health in 1993.

Press Contact: Jane LaBonte (310) 801-3902


'/>"/>
SOURCE Will Rogers Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
2. RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers
3. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
4. Bryan R. Rogers Appointed President of Far West Division
5. National physician organization supports Capps-Rogers Bill at todays congressional briefing
6. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
7. The Risk Management and Patient Safety Institute Announces Annual Health Care Risk Conference Dates
8. LifeNet Health Establishes The Skin & Wound Allograft Institute
9. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
10. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... , ... Current Meditation , a new meditation concept ... U.S. starting this spring. Current Meditation focuses on “meditation for the modern world,” ... will be the first meditation concept in the U.S. offering franchising opportunities, setting ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez has lived ... continued to spiritually evolve, which is the purpose of everyone in this universe. As ... ” (published by Balboa Press) attempts to guide readers to expand one’s spiritual life. ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company that ... its products are coming soon to Amazon.com, the world’s largest online retailer. ... means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 Visiomed, the French ... since 1997, is changing the landscape of healthcare ... patients with pro-active, custom-made solutions. Recognizing the rising ... and affordable healthcare without walls, Visiomed has launched ... developed with healthcare professionals that is empowering the ...
(Date:2/23/2017)... SEOUL , Südkorea, 23. Februar 2017 ... LED für Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache ... kurzwellige ultraviolette Strahlung im Bereich zwischen 200 und 280 nm ... Ausbreitung von Bakterien, indem es ihre DNA zerstört. Das ... 280 nm. ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology: